N-in-1 Dosing Pharmacokinetics in Drug Discovery: Experience, Theoretical and Practical Considerations-Reference-Cited by-同舟云学术

N-in-1 Dosing Pharmacokinetics in Drug Discovery: Experience, Theoretical and Practical Considerations

Published:2008-07 Issue:7 Volume:97 Page:2568-2580
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

He Kan,Qian Mingxin,Wong Harvey,Bai Stephen A.,He Bing,Brogdon Bernice,Grace James E.,Xin Baomin,Wu Jingtao,Ren Shelly X.,Zeng Hang,Deng Yuzhong,Graden Danielle M.,Olah Timothy V.,Unger Steve E.,Luettgen Joseph M.,Knabb Robert M.,Pinto Donald J.,Lam Patrick Y.S.,Duan James,Wexler Ruth R.,Decicco Carl P.,Christ David D.,Grossman Scott J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Managing the drug discovery/development interface;Kennedy;Drug Discov Today,1997

2. Pharmaceutical profiling in drug discovery;Kerns;Drug Discov Today,2003

3. Profiling drug-like properties in discovery research;Di;Curr Opin Chem Biol,2003

4. Combining high-throughput pharmacokinetic screens at the hits-to-leads stage of drug discovery;Spalding;Drug Discov Today,2000

5. Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput;Berman;J Med Chem,1997

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization for small volume of distribution leading to the discovery of apixaban;Overcoming Obstacles in Drug Discovery and Development;2023

2. DMPK Lead Optimization;Discovery DMPK Quick Guide;2022

3. ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated Approaches;Current Drug Metabolism;2021-09-14

4. From basic science to life-saving therapy: the rationale, and drug discovery efforts that led to the direct factor Xa inhibitor eliquis;Journal of Thrombosis and Thrombolysis;2021-08

5. A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients;Frontiers in Pharmacology;2021-05-20